This study gives new insight into the origins of FTE-derived ovarian cancer tumor cell heterogeneity due to loss of PTEN and PAX2, providing a model to study the mechanisms responsible for the emergence of cancer stem cells. This evidence concerns the gene PAX2 and ovarian carcinoma.